Home

Enavate Sciences GP, 10% Owner: Camp4 Therapeutics CAMP Buy · Filed 24/10/17

Trade details

Type
Insider buy
Amount
$14,999,996
Shares · price
1,363,636 sh · $11.00 a share
Held after
3,785,802 sh
Trade date
24/10/15
Filed
24/10/17
Days to filing
2 days

First buy since 2023

Insiders buying this week
29 insiders
Holding change
+56.3%

Camp4 Therapeutics trades, last 26 weeks

What else happened in Camp4 Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/15~24/11/14

Enavate Sciences GP's recent trades

  • Enavate Sciences GP

    BuyZenas BioPharma

    $15M

    Filed 24/09/18